Unknown

Dataset Information

0

Virtual Screening Technology for Two Novel Peptides in Soybean as Inhibitors of α-Amylase and α-Glucosidase.

ABSTRACT: Soybean peptides (SPs) have bioactivities of enzyme inhibition that are beneficial to human health, but their mechanism is not clear. This study aimed to identify peptide fragments in SPs that simultaneously inhibit α-amylase and α-glucosidase and to explore their enzyme inhibition mechanism. Firstly, the inhibitory activity of SPs against the enzymes was determined. And two octapeptides, LDQTPRVF and SRNPIYSN, were identified for the first time by using HPLC-QTOF-MS/MS and virtual screening. Molecular simulation results showed that hydrogen bonds and π-π bonds were the key factors, and the N-terminal (Leu and Ser) and C-terminal (Phe) of peptide were important inhibiting sites. Both octapeptides were synthesized, and their IC50 values were 3.08 and 5.58 mmol/L for α-amylase, and 2.52 and 4.57 mmol/L for α-glucosidase, respectively. This study provided evidence for SPs as a potential inhibitor of α-amylase and α-glucosidase in special dietary foods.

SUBMITTER: Tang X 

PROVIDER: S-EPMC10743026 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Virtual Screening Technology for Two Novel Peptides in Soybean as Inhibitors of α-Amylase and α-Glucosidase.

Tang Xiyao X   Chen Xu X   Wang Hong H   Yang Jinyi J   Li Lin L   Zhu Jie J   Liu Yujia Y  

Foods (Basel, Switzerland) 20231206 24

Soybean peptides (SPs) have bioactivities of enzyme inhibition that are beneficial to human health, but their mechanism is not clear. This study aimed to identify peptide fragments in SPs that simultaneously inhibit α-amylase and α-glucosidase and to explore their enzyme inhibition mechanism. Firstly, the inhibitory activity of SPs against the enzymes was determined. And two octapeptides, LDQTPRVF and SRNPIYSN, were identified for the first time by using HPLC-QTOF-MS/MS and virtual screening. Mo  ...[more]

Similar Datasets

Unknown Momilactones A and B Are α-Amylase and α-Glucosidase Inhibitors.
| S-EPMC6385104 | biostudies-literature
Unknown Discovery of New α-Glucosidase Inhibitors: Structure-Based Virtual Screening and Biological Evaluation.
| S-EPMC7982526 | biostudies-literature
Unknown Machine Learning and In Vitro Chemical Screening of Potential α-Amylase and α-Glucosidase Inhibitors from Thai Indigenous Plants.
| S-EPMC8781461 | biostudies-literature
Unknown Benzimidazole Bearing Thiosemicarbazone Derivatives Act as Potent α-Amylase and α-Glucosidase Inhibitors; Synthesis, Bioactivity Screening and Molecular Docking Study.
| S-EPMC9609971 | biostudies-literature
Unknown Discovery of Novel Pyrrolidine-Based Chalcones as Dual Inhibitors of α-Amylase and α-Glucosidase: Synthesis, Molecular Docking, ADMET Profiles, and Pharmacological Screening.
| S-EPMC11904715 | biostudies-literature
Unknown Gene set enrichment analysis of α-amylase and α-glucosidase inhibitors of <i>Cassia glauca</i>.
| S-EPMC7843725 | biostudies-literature
Unknown α-Glucosidase Inhibitors from Two Mangrove-Derived Actinomycetes.
| S-EPMC10180428 | biostudies-literature
Unknown A Convenient Synthesis of Short α-/β-Mixed Peptides as Potential α-Amylase Inhibitors.
| S-EPMC11396456 | biostudies-literature
Unknown In Silico Approaches to Identify Polyphenol Compounds as α-Glucosidase and α-Amylase Inhibitors against Type-II Diabetes.
| S-EPMC8699780 | biostudies-literature
Unknown Novel Benzimidazole-Endowed Chalcones as α-Glucosidase and α-Amylase Inhibitors: An Insight into Structural and Computational Studies.
| S-EPMC11643225 | biostudies-literature